|
|
|
|
LEADER |
00000cam a2200000Ma 4500 |
001 |
SCIDIR_ocn646756751 |
003 |
OCoLC |
005 |
20231117033229.0 |
006 |
m o d |
007 |
cr cn||||||||| |
008 |
960814s2002 ne a ob 001 0 eng d |
040 |
|
|
|a E7B
|b eng
|e pn
|c E7B
|d OCLCQ
|d UBY
|d OCLCQ
|d OPELS
|d OCLCQ
|d OCLCA
|d OCLCF
|d OCLCQ
|d DEBBG
|d D6H
|d LEAUB
|d SFB
|d OCLCO
|d INARC
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 505096860
|a 1127185997
|a 1136371062
|a 1144394121
|a 1162125313
|
020 |
|
|
|a 0444509593
|q (electronic bk.)
|
020 |
|
|
|a 9780444509598
|q (electronic bk.)
|
020 |
|
|
|a 1281715883
|
020 |
|
|
|a 9781281715883
|
020 |
|
|
|a 9786611715885
|
020 |
|
|
|a 6611715886
|
020 |
|
|
|a 0080515118
|
020 |
|
|
|a 9780080515113
|
035 |
|
|
|a (OCoLC)646756751
|z (OCoLC)505096860
|z (OCoLC)1127185997
|z (OCoLC)1136371062
|z (OCoLC)1144394121
|z (OCoLC)1162125313
|
050 |
|
4 |
|a RS410
|b .P7639 2002eb
|
082 |
0 |
4 |
|a 615.1/9
|2 23
|
245 |
0 |
0 |
|a Progress in medicinal chemistry.
|n Volume 39 /
|c editors, F.D. King and A.W. Oxford.
|
260 |
|
|
|a Amsterdam :
|b North Holland Pub. Co.,
|c �2002.
|
300 |
|
|
|a 1 online resource (274 pages) :
|b illustrations.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
0 |
|
|a Progress in medicinal chemistry ;
|v 39
|
504 |
|
|
|a Includes bibliographical references and index.
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a Front Cover; Progress in Medicinal Chemistry, Volume 39; Copyright Page; Preface; List of Contributors; Contents; Chapter 1. Caspase Inhibitors as Anti-inflammatory and Antiapoptotic Agents; Chapter 2. RNA as a Drug Target; Chapter 3. AC AT Inhibitors: The Search for a Novel and Effective Treatment of Hypercholesterolemia and Atherosclerosis; Chapter 4. Growth Hormone Secretagogues: Discovery of Small Orally Active Molecules by Peptidomimetic Strategies; Chapter 5. Inhibitors of Hepatitis C Virus NS3.4A Protease: An Overdue Line of Therapy; Subject Index; Author Index (Vols. 1-39)
|
520 |
|
|
|a PROG MEDICINAL CHEMIS PMC39H.
|
546 |
|
|
|a English.
|
650 |
|
0 |
|a Pharmaceutical chemistry.
|
650 |
|
0 |
|a Pharmacology.
|
650 |
|
2 |
|a Chemistry, Pharmaceutical
|0 (DNLM)D002626
|
650 |
|
2 |
|a Pharmacology
|0 (DNLM)D010600
|
650 |
|
6 |
|a Chimie pharmaceutique.
|0 (CaQQLa)201-0028674
|
650 |
|
6 |
|a Pharmacologie.
|0 (CaQQLa)201-0007219
|
650 |
|
7 |
|a pharmacology.
|2 aat
|0 (CStmoGRI)aat300137970
|
650 |
|
7 |
|a Pharmaceutical chemistry
|2 fast
|0 (OCoLC)fst01060115
|
650 |
|
7 |
|a Pharmacology
|2 fast
|0 (OCoLC)fst01060259
|
700 |
1 |
|
|a King, Frank D.
|
700 |
1 |
|
|a Oxford, Arnold Whitaker,
|d 1854-
|
776 |
|
|
|z 0-444-50959-3
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780444509598
|z Texto completo
|